Name: Antimalarial Drug Research & Development
SKU: 64755855
Price: 3182.85 MXN
Availability: InStock
Author: Antoine C Banet;Philippe E Brasier
ISBN: 9781629482088

portada Antimalarial Drug Research & Development

Antimalarial Drug Research & Development

Formato

Libro Físico

Editorial

Nova Science Publishers

Autor

Antoine C Banet;Philippe E Brasier

Año

2014

N° páginas

175

Encuadernación

Tapa Dura

Dimensiones

22.9x15.7x1.9 cm

ISBN13

9781629482088

Antimalarial Drug Research & Development

Antoine C Banet;Philippe E Brasier (Autor) · Nova Science Publishers · Tapa Dura

Libro Nuevo Importado

Envío: 12 a 17 días háb.

$ 6,365.70$ 3,182.85

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 2 unidades

$ 3,182.85

¡Envío Gratis! Llega entre el 29 Sep y el 07 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Antimalarial Drug Research & Development"

Malaria-like febrile illnesses have been described since Hippocrates as fevers that were periodic and associated with marshes and swamps. The word "malaria" comes from the Italian "mal''aria" for "bad airs". Malaria is transmitted to humans via the bite of the infected female mosquito of anopheles species. Malaria can exist, in a mild form that is most commonly associated with flu-like symptoms; fever, vomiting, and general malaise. Most disease cases are found in the poorest countries; tropical Africa, Latin America, Southern Asia and Oceania. More concern is being given now to malaria even in countries where there is a low risk of infection due to the phenomena of global warming which is significantly increasing. In this book, the authors present current research in the study of anti-malarial drug research and developments. Topics discussed in this compilation include the anti-malarial atovaquone prodrugs based on enzyme models with molecular orbital calculations approach; new quinoline-based multiple ligands in antimalarial drug development; new molecular scaffolds as potential therapeutic agents to combat antimalarial resistance; and PfCRT mediates sensitivity of chloroquine-resistant P Falciparum to diamidines.